GRANULES Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > granules

Technical Analysis

Technical Strength: 4.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.7. According to RSI analysis, granules is at it's support. 8.0 GRANULES RSI Chart
MACD (?) MACD: 2.7 and Signal Line: 3.05. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 0.0 GRANULES MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, granules is facing resistance from it's 20-day simple moving average at 138.225 and support level is at 134. 5.0 GRANULES Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, granules is facing resistance from it's 20-day exponential moving average at 137.8636 and support level is at 134. 5.0 GRANULES Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.366. 5.0 GRANULES Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% level. Support is at 132.7578 Resistance levels are 136.05 and 139.3422. 6.5 GRANULES Fibonacci Retracement Chart
Average True Range (?) ATR: 5.12 NA GRANULES Average True Range Chart
Average Directional Index (?) ADX is 21.5 which means GRANULES is in a trading range and there is no trend. NA GRANULES Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 18, 2018
Open Price 141.1
High Price 141.8
Low Price 134.7
Close Price 135.85
Absolute Change -4.5
Percentage Change -3.21%
Weekly Change -7.43%
Monthly Change 6.34%
Yearly Change 30.2%
52-week high 157.25
52-week low 101.25
Corporate Actions
ExDate Purpose
November 20, 2017 INT DIV RE 0.25 PER SHARE
September 20, 2017 AGM/DIV-RE 0.25 PER SHARE
August 23, 2017 INT DIV-RE 0.25 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.792
Confidence in Beta5.04%
Market Capital Rs. 2787.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 5.6
TTM Price-to-Earnings (P/E) Ratio 24.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 18 January 2018: Deliverable Quantity:7.92e+05 NA GRANULES Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 18 January 2018: Daily Volatility:0.4069 NA GRANULES Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 18 January 2018: PCR_OI:0.364 PCR:0.385 NA GRANULES PCR Chart
Option Pain (?) 18 January 2018: Max Pain:140.0 NA GRANULES Option Pain Chart
Premium (?) 18 January 2018 Premium: 0.1 Futures OI:15575000.0 NA GRANULES Premium Chart
Option_MAX_OI (?) 18 January 2018: Price:135.85 Put with maximum OI:140.0 Call with maximum OI:150.0 NA GRANULES Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 135.95 15575000.0 974.0 1019.0 135.85
February 22, 2018 136.7 1305000.0 126.0 152.0 135.85

Announcements

December 11, 2017 GrUpdatesranules India Limited has informed the Exchange regarding 'Granules Pharmaceuticals, Inc. completed U.S. FDA inspection.'.
December 07, 2017 GrAnalysts/Institutional Investor Meet/Con. Call Updatesranules India Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 01, 2017 November 09, 2017 inResults/Dividendnter alia, to consider and approve the Un-audited Financial Results for the second quarter ended September 30, 2017 and the payment of second interim dividend for the FY 2017-18, if any.
August 07, 2017 August 14, 2017 InResults/Dividendnter-alia, to consider and approve the Un-audited Financial Results for the first quarter ended June 30, 2017 and the payment of first interim dividend for the FY 2017-18, if any.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 126 Rs. 130.3 Rs. 133.1 Rs. 137.4 Rs. 140.2 Rs. 144.6 Rs. 147.3